Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 5/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 1.00 |
| ▸ | HPGD | P15428 | 4/20 | 1.00 |
| ▸ | MAPK1 | P28482 | 4/20 | 1.00 |
| ▸ | RECQL | P46063 | 3/20 | 1.00 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 3/20 | 1.00 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 1.00 |
| ▸ | MET | P08581 | 3/20 | 1.00 |
| ▸ | KIT | P10721 | 3/20 | 1.00 |
| ▸ | FGFR1 | P11362 | 3/20 | 1.00 |
| ▸ | SRC | P12931 | 3/20 | 1.00 |
| ▸ | KDR | P35968 | 3/20 | 1.00 |
| ▸ | G6PD | P11413 | 2/20 | 1.00 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 1.00 |
| ▸ | MEN1 | O00255 | 2/20 | 1.00 |
| ▸ | ALOX15 | P16050 | 2/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 2/20 | 1.00 |
| ▸ | NSD2 | O96028 | 1/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hematoxylin SCHEMBL29363003 | 1.00 | MAPT (1.00) | MAPTKDM4EHPGDMAPK1RECQL | |
| Hematoxylin SCHEMBL30089789 | 1.00 | MAPT (1.00) | MAPTKDM4EHPGDMAPK1RECQL | |
| Haematoxylin SCHEMBL29366910 | 1.00 | MAPT (1.00) | MAPTKDM4EHPGDMAPK1RECQL | |
| Haematoxylin SCHEMBL1784957 | 1.00 | MAPT (1.00) | MAPTKDM4EHPGDMAPK1RECQL | |
| Haematoxylin SCHEMBL30101752 | 1.00 | MAPT (1.00) | MAPTKDM4EHPGDMAPK1RECQL | |
| Hematoxylin SCHEMBL7026124 | 1.00 | MAPT (1.00) | MAPTKDM4EHPGDMAPK1RECQL | |
| Hematoxylin SCHEMBL29357236 | 1.00 | MAPT (1.00) | MAPTKDM4EHPGDMAPK1RECQL | |
| Hematoxylin SCHEMBL19654 | 1.00 | MAPT (1.00) | MAPTKDM4EHPGDMAPK1RECQL | |
| Hematoxylin SCHEMBL1747 | 1.00 | MAPT (1.00) | MAPTKDM4EHPGDMAPK1RECQL | |
| Hematoxylin SCHEMBL19816198 | 0.99 | MAPT (0.97) | MAPTKDM4EHPGDMAPK1RECQL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026106470-A1 | PORTABLE DEVICE FOR MULTIPLEX STAINING AND ANALYSIS OF HISTOPATHOLOGY SAMPLES | BELTRAN RAMIREZ JESUS RAUL (MX) | 2026-05-21 | — | — | WO | disclosed |
| WO-2026099533-A1 | TREATMENT OF ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) WITH GPBP1 INHIBITORS | UNIVERSITAT DE VALÈNCIA (ES) | 2026-05-15 | — | — | WO | disclosed |
| WO-2025241019-A1 | COMBINATION OF SPIDER VENOM PEPTIDE AND CHEMOTHERAPEUTIC AGENTS, COMPOSITION COMPRISING SPIDER VENOM PEPTIDE, RELATED USES AND KIT | UNIVERSIDADE ESTADUAL DE CAMPINAS (BR) | 2025-11-27 | — | — | WO | disclosed |
| WO-2025233557-A1 | SIGMA-1 RECEPTOR INHIBITING AGENTS FOR TREATING RHEUMATOID ARTHRITIS | UNIVERSIDAD DE GRANADA (ES) | 2025-11-13 | — | — | WO | disclosed |
| WO-2025215274-A1 | METHOD FOR PRODUCING KERATINOCYTES AND FIBROBLASTS | FUNDACIÓN UNIVERSITARIA SAN ANTONIO (UCAM) (ES) | 2025-10-16 | — | — | WO | disclosed |
| WO-2025199602-A1 | PHARMACEUTICAL COMPOSITION COMPRISING MITOGENS AND STRESS CONTROL PATHWAY INHIBITORS FOR THE TREATMENT OF CANCER | INSTITUTO BUTANTAN (BR) | 2025-10-02 | — | — | WO | disclosed |
| EP-4615576-A1 | CELLS BEING HIGHLY ENRICHED IN SASP FACTORS, AND COMPOSITION COMPRISING SAID CELLS | Evomedis GmbH (AT) | 2025-09-17 | — | — | EP | disclosed |
| WO-2025125705-A1 | NUCLEAR BIOMARKERS OF ALZHEIMER'S DISEASE, USES THEREOF AND ASSOCIATED METHODS | CHRMTX SL (ES) | 2025-06-19 | — | — | WO | disclosed |
| WO-2025097230-A1 | MOLECULE OF RECOMBINANT NUCLEIC ACID, EPITOPE OF ALPHA TOXIN OF RECOMBINANT C. NOVYI AND USE THEREOF, EXPRESSION VECTOR, VACCINE COMPOSITION, METHOD FOR PREVENTING OR TREATING CLOSTRIDIOSIS IN AN INDIVIDUAL SUFFERING FROM SAME AND METHOD FOR PRODUCING A VACCINE COMPOSITION AGAINST CLOSTRIDIOSIS | FUNDAÇÃO OSWALDO CRUZ (BR) | 2025-05-15 | — | — | WO | disclosed |
| WO-2025101055-A1 | DEVICE FOR MAKING CUTS AND PROCESSING HISTOLOGICAL SAMPLES | BELTRAN RAMIREZ JESUS RAUL (MX) | 2025-05-15 | — | — | WO | disclosed |
| WO-2022133618-A1 | A GRAFTABLE DEVICE FOR THE RECONSTRUCTION OF BONE DEFECTS (BD) | Universidad de Concepción (CL) | 2022-06-30 | — | — | WO | disclosed |
| WO-2022133621-A1 | IN-VITRO METHOD FOR DIAGNOSING AND PREDICTING THE AGGRESSIVENESS OF THYROID CANCER, AND THE PRECISION SURGERY OPTIONS AND TYPE TO BE USED TO REMOVE A TUMOUR FROM A PATIENT; KIT; REAGENTS FORMING THE KIT; AND USE OF THE REAGENTS AND USE OF MOLECULAR MARKERS AS PART OF THE METHOD | PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE (CL) | 2022-06-30 | — | — | WO | disclosed |
| WO-2022129663-A1 | NEW BIOMATERIAL FOR TISSUE ENGINEERING | UNIVERSIDAD DE GRANADA (ES) | 2022-06-23 | — | — | WO | disclosed |
| WO-2022107054-A1 | INHIBITORS OF THE ADAM17 ENZYME AND COMPOSITIONS COMPRISING THEM FOR THE EFFECTIVE TREATMENT OF COVID-19 | CENTRO DE INVESTIGACIÓN Y DE ESTUDIOS AVANZADOS DEL INSTITUTO POLITÉCNICO NACIONAL (MX) | 2022-05-27 | — | — | WO | disclosed |
| WO-2022074281-A1 | NEW BIOMATERIAL FOR TISSUE ENGINEERING | UNIVERSIDAD DE GRANADA (ES) | 2022-04-14 | — | — | WO | disclosed |
| WO-2022061439-A1 | USE OF THE INFECTIOUS BRONCHITIS VIRUS (IBV), VACCINE FOR IMMUNIZING MAMMALS AGAINST CORONAVIRUS AND METHOD FOR IMMUNIZING MAMMALS AGAINST CORONAVIRUS | FUNDAÇÃO UNIVERSIDADE ESTADUAL DO CEARÁ - FUNECE (BR) | 2022-03-31 | — | — | WO | disclosed |
| WO-2022049320-A1 | NAD+ PRECURSORS FOR USE IN THE PREVENTION AND/OR TREATMENT OF HEREDITARY AORTIC ANEURYSMS | FUNDACIÓN PARA LA INVESTIGACIÓN BIOMEDICA DEL HOSPITAL 12 DE OCTUBRE (ES) | 2022-03-10 | — | — | WO | disclosed |
| WO-2022032368-A1 | METHOD FOR PRODUCING AN ANTIGEN CORRESPONDING TO THE INACTIVATED SARS-COV-2 VIRUS, ANTIGEN CORRESPONDING TO THE INACTIVATED SARS-COV-2 VIRUS, ANTIGENIC COMPOSITION, KITS, AND USES THEREOF | INSTITUTO BUTANTAN (BR) | 2022-02-17 | — | — | WO | disclosed |
| WO-2022035306-A2 | USE OF COLLAGEN-POLYVINYLPYRROLIDONE IN PULMONARY INFLAMMATION AND FIBROSIS IN PATIENTS INFECTED BY THE SARS-COV2 VIRUS (COVID-19) | ASPID S.A. DE C.V. (MX) | 2022-02-17 | — | — | WO | disclosed |
| WO-2022019740-A1 | AUTOMATIC DEVICE FOR DYEING MULTIPLE HISTOLOGICAL SAMPLES | BELTRAN RAMIREZ JESUS RAUL (MX) | 2022-01-27 | — | — | WO | disclosed |